Abstract
Synapse formation is a process tightly controlled in space and time. How gene regulatory mechanisms specify spatial and temporal aspects of synapse formation is not well understood. In the nematode C.elegans, two subtypes of the D-type inhibitory motor neuron (MN) classes, the dorsal D (DD) and ventral D (VD) neurons, extend axons along both the dorsal and ventral nerve cords 1. The embryonically generated DD MNs initially innervate ventral muscles in the first (L1) larval stage and receive their synaptic input from cholinergic MNs in the dorsal cord. They rewire by the end of the L1 molt to innervate dorsal muscles and to be innervated by newly formed ventral cholinergic MNs 1. VD MNs develop after the L1 molt; they take over the innervation of ventral muscles and receive their synaptic input from dorsal cholinergic MNs. We show here that the spatiotemporal control of synaptic wiring of the D-type neurons is controlled by an intersectional transcriptional strategy in which the UNC-30 Pitx-type homeodomain transcription factor acts together in embryonic and early larval stages with the temporally controlled LIN-14 transcription factor to prevent premature synapse rewiring of the DD MNs and, together with the UNC-55 nuclear hormone receptor, to prevent aberrant VD synaptic wiring in later larval and adult stages. A key effector of this intersectional transcription factor combination is a novel synaptic organizer molecule, the single immunoglobulin domain protein OIG-1. OIG-1 is perisynaptically localized along the synaptic outputs of the D-type MNs in a temporally controlled manner and is required for appropriate selection of both pre- and post-synaptic partners.
At the end of the first larval stage (L1), the synaptic outputs from the DD MNs to ventral muscle and their synaptic input from cholinergic DA/DB MNs is eliminated and, instead, synapses are formed onto dorsal muscle and synaptic input is received from cholinergic VA/VB MNs (Fig.1a)1. We sought to examine how the spatiotemporal specificity of this rewiring process is controlled and integrated with other aspects of D-type MN differentiation. To address this question, we examined the function of the C. elegans Pitx-type homeobox transcription factor UNC-30, which is known to control GABAergic neurotransmitter identity of the D-type MNs 2,3. The analysis of serial electron micrographs shows that the synaptic patterns of the DD and VD neurons are substantially disrupted in unc-30 null mutant animals. In adult unc-30(0) animals, VD MNs display ectopic synapses onto dorsal muscle and lack significant synaptic inputs from DA/DB on the dorsal side (Fig.1b; Extended Data Fig. 1). Furthermore, DD MNs which normally only synapse onto ventral muscle, show aberrant innervation of dorsal muscle in L1 stage unc-30 mutants (Fig.1c). These synaptic defects were confirmed with GFP-tagged RAB-3 protein, expressed specifically in D-type MNs (Fig.1d).
unc-30 is expressed in both DD and VD MNs at all stages 3, yet unc-30 inhibits dorsal DD synapses only in the L1 stage and not at later stages. However, at these later stages, unc-30 does inhibit dorsal synapses from VD neurons, but not the DD neurons. How can the temporal and spatial specificity of unc-30(e191) defects be explained? A potential answer to this question lies in the previously described mutant phenotype of two transcription factors, which recapitulate specific components of the cell-type specific, DD and VD synaptogenic defects of unc-30 mutants. In animals lacking the lin-14 transcription factor, whose expression is normally temporally restricted to embryonic and first larval stages in most tissues, including the D-type motorneurons 4,5, DD MNs form ectopic synapses in the dorsal cord in embryonic and L1 stages (Extended Data Fig. 2a; schematized in Fig.1e,f)4. These DD MN defects are similar to those that we observe in unc-30 mutants. The dorsal ectopic synapses in the VD neurons of unc-30 mutant animals (not observed in lin-14) are in turn recapitulated in animals lacking the unc-55 orphan nuclear receptor, in which VD MNs form aberrant synapses in the dorsal cord, as previously shown (Extended Data Fig. 2b; schematized in Fig.1e,f)6,7, while DD wiring at the L1 stage is normal. Taken together, the unc-30 phenotype in the DD and VD neurons can be viewed as a “composite” of the two individual phenotypes of lin-14 (DD neurons at L1 stage) and unc-55 (VD neurons at later stages) (Fig.1e,f schematic). One possible way to explain these concordances of phenotypes is that unc-30 may collaborate with lin-14 to control the expression of a molecule that acts in a temporally restricted manner in embryonic and L1 stages to inhibit dorsal synapse formation of the DD neurons. In the VD MNs, unc-30 may in turn collaborate with unc-55 to control expression of a molecule that acts in the VD neurons to inhibit dorsal synapse formation of these neurons.
We sought to identify such potential effector molecule(s) through a candidate gene approach. In a survey of C. elegans immunoglobulin superfamily members, we had previously described a family of small proteins that are composed of a single Ig domain, the oig gene family 8. One of the oig family members, oig-1, encodes a 137aa long protein with a signal sequence, a single IgC2-type domain but no transmembrane domain or predicted GPI anchor. Transgenic animals carrying an oig-1 fosmid-based reporter construct showed expression both in the DD and VD MNs, but no other ventral nerve cord MNs (Fig.2a). Notably, expression of oig-1 in the D-type MNs is temporally controlled in a manner that correlates with the distinct periods of inhibition of dorsal muscle innervation exhibited by DD and VD neurons. oig-1 is transiently expressed in the DD neurons during the time when no dorsal synapses are formed (embryos and L1), but is downregulated in the DD neurons upon formation of their dorsal synapses (L2 and later; Fig.2a). In contrast, expression of oig-1 in the VD neurons, which have processes but no synaptic outputs in the dorsal cord, is continuously maintained throughout the life of the neuron (Fig.2a).
The transient expression in the DD and continuous expression in the VD neurons makes oig-1 a candidate effector gene for the unc-30, lin-14 and unc-55 transcription factors. Indeed, the oig-1fosmid::sl2::gfp reporter fails to be expressed in both DD- and VD-type MNs in unc-30 null mutants at all stages (Fig.2b). In lin-14 null mutant animals, transient expression of the oig-1 reporter in the L1 stage is diminished in the DD MNs (Fig.2b) and temporally prolonged expression of lin-14, achieved through genetic removal of a negative regulator of lin-14, the miRNA lin-4 9, results in prolonged expression of oig-1 in the DD MNs into the adult stage (Fig.2b). In animals lacking unc-55, which is normally expressed in VD, but not DD MNs 10, expression of oig-1 in the DD neurons at the L1 stage is unaffected but oig-1 expression in the VD neurons is absent at the adult stage (Fig.2b). The two distinct transcription factor combinations that control oig-1 expression in DD (unc-30 and lin-14) and in VD (unc-30 and unc-55) operate independently since the expression of each transcription factor is independent of the presence of the other transcription factor (Extended Data Fig. 3a,b)11.
The transcriptional nature of oig-1 regulation is corroborated by the finding that 1kb of 5’ sequences of oig-1 conveys the same spatiotemporal regulation as the oig-1 fosmid reporter (Extended Data Fig. 4), Chromatin immunoprecipitation-sequencing data from the modEncode project shows binding of UNC-55 to this 1kb fragment of the oig-1 locus 12, suggesting direct regulation. A 125bp element that still recapitulates spatiotemporal control in the D-type MN expression contains two sites with partial match to the UNC-30 binding site 13 and one is required for DD MN expression (Extended Data Fig. 4).
The expression pattern of oig-1 and its regulation by transcription factors that regulate synapse formation make oig-1 a candidate to be involved in the synapse-organizing activity of these transcription factors. Animals that carry an oig-1 deletion allele (Fig.2a) are viable and fertile, but display locomotory defects and hypersensitivity to the drug aldicarb (Extended Data Fig. 5a,b), which is characteristic of abnormalities in GABAergic signaling 14. In embryonic and L1 stages when only the DD MNs are present, the presynaptic vesicle protein SNB-1 and RAB-3 are aberrantly clustered along the dorsal nerve cord of oig-1 null mutants (Fig.3a; Extended Data Fig. 2c). Moreover, the postsynaptic GABA receptor UNC-49 15, which normally clusters on ventral muscle at the L1 stage, clusters ectopically along the dorsal nerve cord (Fig.3b). Therefore, oig-1 – like its upstream regulators unc-30 and lin-14 - is required to prevent premature DD synapse formation in the dorsal nerve cord.
Examining the synapses of the VD MN that normally exclusively form synapses on ventral muscle, we observed more puncta of three presynaptic markers (SNB-1 and RAB-3 proteins and the Liprin-α protein SYD-2) in the dorsal nerve cord and less in the ventral nerve cord of oig-1 mutants at post-L1 larval stages (Fig.3c; Extended Data Fig. 2c). This suggests the VD MNs have aberrant synaptic specializations in the dorsal nerve cord in oig-1 mutants; while less severe, this phenotype is similar to those of the VD synaptic defects of unc-30 and unc-55 mutants.
We next examined whether oig-1 function is restricted to controlling the synaptic output of D-type neurons or whether oig-1 may also affect localization of their synaptic input. Innervation of the DD and VD neurons from the cholinergic A- and B-type neurons can be visualized with GFP-tagged ACR-12 protein 16 which localizes to puncta in the DD neurons in the dorsal nerve cord in the L1 stage, indicative of the cholinergic input from the DA/DB MNs (Fig.4a). Strikingly, in oig-1 mutants, these dorsal puncta are not observed (Fig.4a). In post L1-stage wild-type animals, ACR-12 protein normally labels synapses from DA/DB to the VD neurons in the dorsal cord and synapses from VA/VB to the DD neurons in the ventral cord (Fig.4b). In oig-1 mutants, the dorsal, ACR-12(+) synaptic inputs in the VD neurons also do not form properly (Fig.4b). The coincidence of synaptic input and synaptic output defects in oig-1 mutants indicates that the localization of synaptic in- and outputs are coordinated and that this coordination requires the OIG-1 protein. As expected, the oig-1 defects in synaptic innervation, as determined by ACR-12 clustering, are mirrored by loss of the temporal (lin-14) and spatial (unc-55) specificity regulators of oig-1 expression (Extended Data Fig. 6a,b).
The synaptic defects (as well as the locomotory defects) of oig-1 mutants can be rescued by expressing oig-1 specifically in the D-type MN under control of the unc-30 promoter whereas expression under control of a cholinergic A- and B-type MN promoter does not rescue (Fig.3a,c Extended Data Fig. 5a,c). Since OIG-1 is predicted to encode a secreted protein, the lack of rescue of oig-1 with a cholinergic promoter suggests that OIG-1 protein functions cell-autonomously in/on the GABAergic DD and VD classes of MNs and argues against a long-range, diffusible function of OIG-1. Consistent with this autonomy, oig-1 mutants show no defects in the localization of synapses of the adjacent cholinergic MNs (data not shown). The rescuing activity of oig-1 critically depends on the integrity of the IgC2 domain (Extended Data Fig. 7). Forced expression of oig-1 in the D-type MNs under control of two promoters that are not downregulated in the D-type motor neurons (unc-25 and unc-30 promoters) is not sufficient to prevent the formation of dorsal synaptic outputs of the DD neurons (data not shown), indicating that oig-1 collaborates with other factors to regulate synapse formation.
The synaptic wiring defects in oig-1 mutants suggested the OIG-1 protein might be localized in a spatially restricted manner in the DD and VD MNs. A fosmid-based reporter in which OIG-1 protein is fused to GFP (and which rescues oig-1 locomotory defects and the aldicarb hypersensitivity; Fig.2a; Extended Data Fig. 5a,b) shows punctate localization along the processes of the D-type MNs (Fig.5a). The punctate pattern of OIG-1 in D-type MNs revealed a surprising localization pattern along the D-type processes. At the L1 stage, OIG-1 is not localized along the dorsal processes (in which the synaptic wiring defects are observed), but is localized along the ventral cord. After the generation of the VD MNs (and extinction of OIG-1 expression in the DD MNs, as described above), OIG-1 protein also localized in the VD neurons along the ventral cord. Co-labeling with the presynaptic RIM protein UNC-10 and the postsynaptic GABA receptors UNC-49 demonstrates that these puncta correspond to the perisynaptic region of synapses that D-type MNs form onto ventral muscle (Fig.5b). When ectopically expressed in excitatory cholinergic VNC or head MNs, OIG-1::GFP is also targeted to presynaptic specializations (Fig.5c), demonstrating that OIG-1 localization is not dependent on GABAergic specific synaptic features, but rather contains presynaptic targeting properties that are independent of the type of synapse. Taken together, the perisynaptic localization pattern of OIG-1 indicates that a highly localized, synaptic organizer protein is capable of orchestrating the wiring properties of an entire neuron, by promoting synaptic input and preventing ectopic synaptic output in a distal portion of the neuronal process (Fig.5b). Punctate OIG-1 protein is also observed in a few head neurons (Extended Data Fig. 8).
The mutant phenotype of oig-1, specifically the aberrant formation of synaptic output from dorsal DD and VD axons, resembles the mutant phenotype observed upon removal of the SAD-1 kinase 17-19. In animals lacking sad-1 or lacking strd-1/STRADα, a pseudokinase required for SAD-1 localization 20, OIG-1 clusters ectopically along the dorsal nerve cord (Extended Data Fig. 9). Conversely, loss of oig-1 does not affect localization of SAD-1 (data not shown). What sets OIG-1 apart from these molecules is that in contrast to the panneuronally expressed SAD-1 and STRADα , OIG-1 appears to operate as a spatiotemporally controlled nexus of this pathway that determines the spatiotemporal specificity of SAD-1 protein function in the context of the D-type MNs. The ability of ventrally and presynaptically localized OIG-1 to organize distally located synaptic inputs and outputs on the dorsal neurite, suggests that OIG-1 may trigger a cascade of downstream signaling events or anchor factors on the ventral side which would otherwise contribute to synapse organization on the dorsal side.
In conclusion, we have shown here that three different transcription factors cooperate in an intersectional manner in defined spatial and temporal contexts to control the expression of a perisynaptically-localized organizer molecule, OIG-1, which orchestrates the localization of synaptic outputs and inputs of two different neuron types (Fig.5d). unc-30 needs to cooperate with other transcription factors and these collaborators confer spatiotemporal specificity. In embryonic and L1 stages, spatially but not temporally restricted unc-30 cooperates with temporally, but not spatially controlled lin-14 to prevent DD MN synapse assembly at the inappropriate location via induction of oig-1 expression. After the L1 stage, the DD/VD-expressed unc-30 collaborates with the subtype (VD)-specific unc-55 transcription factor to restrict oig-1 expression to the VD neurons where it organizes synaptic in- and outputs (Fig.5d).
Our findings demonstrate that the localization of synaptic in- and outputs of a neuron are coordinated and that this coordination is apparently achieved, at least in part, by the OIG-1 organizer protein. It will be interesting to examine whether similar synaptic organizer functions can be ascribed to any of the multiple small, 1-Ig domain proteins, some secreted, some transmembrane, encoded in the C. elegans genome 21, but also in vertebrate genomes 22.
METHODS
C. elegans strains
Worms were grown at 20°C on nematode growth media (NGM) plates seeded with bacteria (E.coli OP50) as a food source. L1 animals were obtained by hypochlorite-treating gravid adult animals and letting embryos hatch and arrest in M9 for 16-18 hours.
Mutant alleles used in this study: LGI: unc-55(e1170) , LGII: lin-4(e912), LGIII: oig-1(ok1687), strd-1(ok2283), LGIV: unc-30(191), LGX: lin-14(ma135), alr-1(oy42), sad-1(ky289), acr-12(ok367)
Transgenes
otEx5663 (unc-302.4kbprom::GFP::RAB-3::unc-103’UTR) used in Fig.1a, Extended Data Fig. 2, otEx4816 (oig-1fosmid::sl2::gfp), otIs450 (oig-1fosmid::sl2::gfp) used in Fig.2., otEx5651 (unc-302.4kbprom::gfp) used in Extended Data Fig. 3a, wgIs395 (unc-30fosmid::TY1::EGFP::3xFLAG) used in Extended Data Fig. 3a, otEx5765 (lin-14fosmid::gfp) used in Extended Data Fig. 3b, juIs1 (unc-25p::snb-1::GFP)4 used in Fig.3a,c, Extended Data Fig. 5c,7, otEx4955 (unc-302.4kbprom::oig-1 line 1) used in Fig.3a,c, Extended Data Fig. 5a,c otEx4956 (unc-302.4kbprom::oig-1 line 2) used in Fig3a,c otEx4941 (unc-3prom::oig-1 line 1) used in Fig.3a,c Extended Data Fig. 5c, otEx4942 (unc-3prom::oig-1 line 2) used in Fig. 3a,c hpIs3 (unc-25p::syd-2::GFP)26 used in Fig.3c, ufIs92 (unc-47prom::ACR-12::GFP)16 used in Fig.4, Extended Data Fig. 6, otEx5664 (oig-1fosmid::gfp) used in Fig.5a,b, Extended Data Fig. 5a,b,8,9, otEx5858 (unc-3558bpprom::OIG-1::GFP) used in Fig.5c, otEx5859 (del-1488bpprom::OIG-1::GFP) used in Fig.5c, otEx6212 (unc-302.4kbprom::oig-1E64A line 1) used in Extended Data Fig. 7, otEx6213 (unc-302.4kbprom::oig-1E64A line 2) used in Extended Data Fig. 7, otEx6214 (unc-302.4kbprom::oig-1W75A line 1) used in Extended Data Fig. 7, otEx6215 (unc-302.4kbprom::oig-1W75A line 2) used in Extended Data Fig. 7.
oig-1 promoter bashing constructs (all used in Extended Data Fig. 4): otEx5993 (oig-1prom1::NLS::gfp line 1), otEx5994 (oig-1prom1::NLS::gfp line 2), otEx5995 (oig-1prom1::NLS::gfp line 3), otEx5996 (oig-1prom2::NLS::gfp line 1), otEx5997 (oig-1prom2::NLS::gfp line 2), otEx5998 (oig-1prom2::NLS::gfp line 3), otEx6003 (oig-1prom3:NLS::gfp line 1), otEx6004 (oig-1prom3::NLS::gfp line 2), otEx6005 (oig-1prom3::NLS::gfp line 3), otEx6006 (oig-1prom4::NLS::gfp line 1), otEx6007 (oig-1prom4::NLS::gfp line 2), otEx6008 (oig-1prom4::NLS::gfp line 3), otEx6009 (oig-1prom5::NLS::gfp line 1), otEx6010 (oig-1prom5::NLS::gfp line 2), otEx6011 (oig-1prom5::NLS::gfp line 3), otEx6034 (oig-1prom6::NLS::gfp line 1), otEx6035 (oig-1prom6::NLS::gfp line 2), otEx6036 (oig-1prom6::NLS::gfp line 3), otEx6037 (oig-1prom7::NLS::gfp line 1), otEx6038 (oig-1prom7::NLS::gfp line 2), otEx6039 (oig-1prom7::NLS::gfp line 3), otEx6060 (oig-1prom8::NLS::gfp line 1), otEx6061 (oig-1prom8::NLS::gfp line 2), otEx6121 (oig-1prom9::NLS::gfp line 1), otEx6122 (oig-1prom9::NLS::gfp line2), otEx6079 (oig-1prom10::NLS::gfp line 1), otEx6080 (oig-1prom10::NLS::gfp line 2), otEx6081 (oig-1prom10::NLS::gfp line 3)
Generation of oig-1 transgenes
The oig-1fosmid::sl2::gfp reporter (shown in Fig.2) was generated by fosmid recombineering using the fosmid WRM0614cC07 and a SL2-based, nuclear-localized gfp cassette, pBALU9 27. The inclusion of the SL2 sequence results in the production of nuclear localized GFP protein. The reporter was injected at 10ng/μl with rol-6(su1006) at 2ng/μl and sonicated OP50 genomic DNA at 120ng/μl. An extrachromosomal array (otEx4816) was integrated to yield otIs450 IV.
The oig-1 translational fosmid gfp reporter, oig-1fosmid::gfp (shown in Fig.5) was generated by fosmid recombineering using the fosmid WRM0614cC07 and a gfp cassette pBALU25, modified from pBALU1 27. pBALU25 was created by mutating the coding sequence of gfp in pBALU1 to contain the amino acid changes F64L and S65T. This cassette was recombineered and inserted into the oig-1 fosmid immediately following the predicted signal peptide sequence (after the 72nd base pair of oig-1). This translational reporter was injected at 10ng/μl with ttx-3prom::mCherry at 3ng/μl and sonicated OP50 genomic DNA at 120ng/μl.
The unc-3558bpprom::OIG-1::GFP construct was generated by TOPO cloning a PCR fusion of 558bp upstream of the unc-3 translational start site with a fragment of the oig-1fosmid::gfp construct containing from the oig-1 translational start site to 500bp downstream of the stop codon. This construct was PCR-amplified from the start of the unc-3 promoter to 500bp downstream of the oig-1 locus and injected at 10ng/μl with ttx-3prom::mCherry at 3ng/μl and sonicated OP50 genomic DNA at 120ng/μl.
The del-1488bpprom::OIG-1::GFP construct was generated by TOPO cloning as the unc-3558bpprom::OIG-1::GFP with 488bp upstream of the del-1 translational start site. This construct was PCR-amplified from the start of the del-1 promoter to 500bp downstream of the oig-1 locus and injected at 10ng/μl with ttx-3prom::mCherry at 3ng/μl and sonicated OP50 genomic DNA at 120ng/μl.
The unc-30p::oig-1 construct was generated by cloning the 2.4kb unc-30 promoter into the EcoRV site of the first MCS of pPD49.26 and the oig-1 locus from the start to stop codon (1521bp) into the BamHI site of the second MCS. This construct was digested with PvuI and injected at 5ng/μl with myo-2p::gfp at 3ng/μl and OP50 genomic DNA at 120ng/μl. Site directed mutagenesis of this construct was used to generate unc-30p::oig-1E64A and unc-30p::oig-1W75A. These constructs were injected as described above.
The unc-3p::oig-1 construct was generated by cloning the 558bp unc-3 promoter into the EcoRV site of the first MCS of pPD49.26 and the oig-1 locus from the start to stop codon (1521bp) into the BamHI site of the second MCS. This construct was digested with PvuI and injected at 10ng/μl with myo-2p::gfp at 3ng/μl and OP50 genomic DNA at 120ng/μl.
The oig-1 promoter deletion constructs were generated by cloning the various promoter fragments into the HindIII and BamHI sties of the MSC of a 2XNLSGFP plasmid. Promoter constructs with potential UNC-30 binding sites deleted were generated using site-directed mutagenesis. These constructs were injected at 50ng/μl with rol-6 at 30ng/μl and rol-6(su1006) at 20ng/μl.
Wormtracker assays
Tracking assays were performed as previously described 28. Briefly, L4 animals were placed on an NGM plate seeded with 20 μl of OP50 bacteria in the center. Automated tracking was performed with the Worm Tracker 2.0 (WT2) which uses a camera to track and record individual worms. Twenty worms of each genotype were tracked for 5 minutes each at 20°C. Analysis was performed as previously described 28.
Aldicarb assays
Aldicarb assays were performed as previously described (Mahoney et al., 2006). Briefly, ~20 young adult animals (24hrs after L4 stage, blinded for genotype) were picked to freshly seeded NGM plates containing1mM aldicarb (ChemService). Worms were assayed for paralysis every 15 minutes by prodding with a platinum wire. A worm was considered paralyzed if it did not respond to prodding to the head and tail three times each at a given time point. Strains were grown and assayed at 20°C.
Antibody staining
Antibody staining was performed at previously described 29. Briefly, following a freeze-crack procedure, worms were fixed by a treatment in ice-cold acetone for 5 minutes and then ice-cold methanol for 5 minutes. Worms were collected in 1X PBS and centrifuged briefly. The PBS was removed and worms were incubated in a blocking solution (1XPBS, 0.2% gelatin, 0.25% Triton X-100) for 30 minutes at 20°C. After the blocking solution was removed, worms were incubated with primary antibodies diluted in PGT (1X PBS, 0.1% gelatin, 0.25% Triton X-100) overnight at 4°C. The anti-UNC-49 antibody (Gally and Bessereau 2003) was used at a 1:500 dilution. The anti-UNC-17 antibody 30 was used at a 1:3000 dilution. The anti-GFP antibody (Life Technologies A10262) was used at 1:1000. The anti-RIM2 (used to recognize UNC-10) was used at a 1:10 dilution (Developmental Studies Hybridoma Bank – University of Iowa). Worms were washed 5 times in wash solution (1XPBS, 0.25% Triton X-100) for 20 minutes each wash. Worms were then incubated with secondary antibodies diluted 1:1000 in PGT for 3 hours at 20°C. Alexa Fluor 488 goat anti-chicken (Invitrogen A11039) was used to detect the anti-GFP antibody. Alexa Fluor 594 donkey anti-mouse (Invitrogen A-21203) was used to detect the anti-RIM2 antibody. Alexa Fluor 555 donkey anti-rabbit (Invitrogen A-31572) was used to detect the anti-UNC-49 antibody. Alexa Fluor 488 donkey anti-mouse (Invitrogen A-21202) was used to detect the anti-UNC-17 antibody. Worms were then washed 5 times for 20 minutes each wash. Following the final wash, worms were mounted in Fluorogel with Tris buffer (Electron Microscopy Sciences).
Statistical Analysis
For results shown in Fig.3a,b, Fig.4a,b, 6a,c, 7, 9, we performed Fisher’s exact test, **p<0.01, *p<0.05. For results shown in Fig.3c, Extended Data Fig. 2c, we performed a Student’s t-test (2 sided, type 2), **p<0.01, *p<0.05. For WormTracker analysis in Extended Data Fig. 3a, we used Wilcoxon rank sum to test the differences between oig-1, wild-type, and rescued strains, **q<0.01, *q<0.05.
Extended Data
ACKNOWLEDGEMENTS
We thank the Transgeneome project, the CGC, J.L. Bessereau, M. Gendrel, S.Y. Kerk for reagents, Q. Chen for microinjection, E. Southgate and N. Thomson for EM analsys, S. Brenner for first noting the neural defects of unc-30(e191), E. Yemini for assistance with worm tracking, and D.Miller, S.He, I. Greenwald and members of the Hobert lab for comments on this manuscript. This work was funded by the National Institutes of Health [R01NS039996-05 and R01NS050266-03], the Howard Hughes Medical Institute and the UK Medical Research Council.
Footnotes
DECLARATION
The authors declare no competing interests.
REFERENCES
- 1.White JG, Albertson DG & Anness MA Connectivity changes in a class of motoneurone during the development of a nematode. Nature 271, 764–6 (1978). [DOI] [PubMed] [Google Scholar]
- 2.Eastman C, Horvitz HR & Jin Y Coordinated transcriptional regulation of the unc-25 glutamic acid decarboxylase and the unc-47 GABA vesicular transporter by the Caenorhabditis elegans UNC-30 homeodomain protein. J Neurosci 19, 6225–34 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jin Y, Hoskins R & Horvitz HR Control of type-D GABAergic neuron differentiation by C. elegans UNC-30 homeodomain protein. Nature 372, 780–3 (1994). [DOI] [PubMed] [Google Scholar]
- 4.Hallam SJ & Jin Y lin-14 regulates the timing of synaptic remodelling in Caenorhabditis elegans. Nature 395, 78–82 (1998). [DOI] [PubMed] [Google Scholar]
- 5.Ruvkun G & Giusto J The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch. Nature 338, 313–9 (1989). [DOI] [PubMed] [Google Scholar]
- 6.Walthall WW & Plunkett JA Genetic transformation of the synaptic pattern of a motoneuron class in Caenorhabditis elegans. J Neurosci 15, 1035–43 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hedgecock EM, Culotti JG, Hall DH & Stern BD Genetics of cell and axon migrations in Caenorhabditis elegans. Development 100, 365–82 (1987). [DOI] [PubMed] [Google Scholar]
- 8.Aurelio O, Hall DH & Hobert O Immunoglobulin-domain proteins required for maintenance of ventral nerve cord organization. Science 295, 686–90 (2002). [DOI] [PubMed] [Google Scholar]
- 9.Wightman B, Ha I & Ruvkun G Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855–62 (1993). [DOI] [PubMed] [Google Scholar]
- 10.Zhou HM & Walthall WW UNC-55, an Orphan Nuclear Hormone Receptor, Orchestrates Synaptic Specificity among Two Classes of Motor Neurons in Caenorhabditis elegans. J Neurosci 18, 10438–10444 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shan G, Kim K, Li C & Walthall WW Convergent genetic programs regulate similarities and differences between related motor neuron classes in Caenorhabditis elegans. Dev Biol 280, 494–503 (2005). [DOI] [PubMed] [Google Scholar]
- 12.Araya CL et al. Regulatory analysis of the C. elegans genome with spatiotemporal resolution. Nature 512, 400–5 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cinar H, Keles S & Jin Y Expression profiling of GABAergic motor neurons in Caenorhabditis elegans. Curr Biol 15, 340–6 (2005). [DOI] [PubMed] [Google Scholar]
- 14.Miller KG et al. A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A 93, 12593–8 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bamber BA, Beg AA, Twyman RE & Jorgensen EM The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci 19, 5348–59 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Petrash HA, Philbrook A, Haburcak M, Barbagallo B & Francis MM ACR-12 ionotropic acetylcholine receptor complexes regulate inhibitory motor neuron activity in Caenorhabditis elegans. J Neurosci 33, 5524–32 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Crump JG, Zhen M, Jin Y & Bargmann CI The SAD-1 Kinase Regulates Presynaptic Vesicle Clustering and Axon Termination. Neuron 29, 115–129. (2001). [DOI] [PubMed] [Google Scholar]
- 18.Kim JS, Hung W & Zhen M The long and the short of SAD-1 kinase. Commun Integr Biol 3, 251–5 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Shelly M & Poo MM Role of LKB1-SAD/MARK pathway in neuronal polarization. Dev Neurobiol 71, 508–27 (2011). [DOI] [PubMed] [Google Scholar]
- 20.Kim JS, Hung W, Narbonne P, Roy R & Zhen MC elegans STRADalpha and SAD cooperatively regulate neuronal polarity and synaptic organization. Development 137, 93–102 (2010). [DOI] [PubMed] [Google Scholar]
- 21.Hobert O The neuronal genome of Caenorhabditis elegans. WormBook, 1–106 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Letunic I, Doerks T & Bork P SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res 40, D302–5 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hong Y, Lee RC & Ambros V Structure and function analysis of LIN-14, a temporal regulator of postembryonic developmental events in Caenorhabditis elegans. Mol Cell Biol 20, 2285–95 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Melkman T & Sengupta P Regulation of chemosensory and GABAergic motor neuron development by the C. elegans Aristaless/Arx homolog alr-1. Development 132, 1935–49 (2005). [DOI] [PubMed] [Google Scholar]
- 25.Rapti G, Richmond J & Bessereau JL A single immunoglobulin-domain protein required for clustering acetylcholine receptors in C. elegans. Embo J 30, 706–18 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
REFERENCES FOR ONLINE MATERIAL
- 26.Yeh E, Kawano T, Weimer RM, Bessereau JL & Zhen M Identification of genes involved in synaptogenesis using a fluorescent active zone marker in Caenorhabditis elegans. J Neurosci 25, 3833–41 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tursun B, Cochella L, Carrera I & Hobert O A toolkit and robust pipeline for the generation of fosmid-based reporter genes in C. elegans. PLoS ONE 4, e4625 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yemini E, Jucikas T, Grundy LJ, Brown AE & Schafer WR A database of Caenorhabditis elegans behavioral phenotypes. Nat Methods 10, 877–9 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gendrel M, Rapti G, Richmond JE & Bessereau JL A secreted complement-control-related protein ensures acetylcholine receptor clustering. Nature 461, 992–6 (2009). [DOI] [PubMed] [Google Scholar]
- 30.Duerr JS, Han HP, Fields SD & Rand JB Identification of major classes of cholinergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 506, 398–408 (2008). [DOI] [PubMed] [Google Scholar]
- 31.White JG, Southgate E, Thomson JN & Brenner S The structure of the nervous system of the nematode Caenorhabditis elegans. Philosophical Transactions of the Royal Society of London B. Biological Sciences 314, 1–340 (1986). [DOI] [PubMed] [Google Scholar]
- 32.Li J & Greenwald I LIN-14 inhibition of LIN-12 contributes to precision and timing of C. elegans vulval fate patterning. Curr Biol 20, 1875–9 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]